Monitoring the progression of IBD is crucial for effective management. Nanosensors can be deployed to continuously monitor inflammation markers in the gut. These sensors can be integrated into ingestible devices that transmit real-time data to healthcare providers. Additionally, nanofiber-based scaffolds can be used in endoscopic procedures to collect tissue samples for detailed analysis, providing a more comprehensive picture of the disease state.
